Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4–16
Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720
Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 7:983–989
Krag DN, Anderson SJ, Julian TB, National Surgical Adjuvant Breast and Bowel Project et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888
Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933
Takei H, Kurosumi M, Yoshida T et al (2007) Current trends of sentinel lymph node biopsy for breast cancer—a surgeon’s perspective. Breast Cancer 14:362–370
Nieweg OE, Estourgie SH (2004) What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 11:169S–173S
Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151
Gur AS, Unal B, Johnson R et al (2009) Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208:229–235
Rivers AK, Griffith KA, Hunt KK et al (2006) Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 13:36–44
Alkhatib W, Connor C, Fang F (2007) Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg 194:856–859
Katz A, Smith BL, Golshan M et al (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093–2098
Takei H, Kurosumi M, Yoshida T et al (2009) Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer. Breast 18:244–247
Park J, Fey JV, Naik AM et al (2007) A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245:462–468
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483–2493
van Nes JG, Putter H, Julien JP et al (2009) Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902. Breast Cancer Res Treat 115:101–113
Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694–2702
Classe JM, Bordes V, Campion L et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27:726–732
Buchholz TA, Lehman CD, Harris JR et al (2008) Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol 26:791–797
Takei H, Suemasu K, Kurosumi M et al (2002) Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer 9:344–348
Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216
Takei H, Suemasu K, Kurosumi M et al (2006) 99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer. Surg Today 36:219–224
Takei H, Suemasu K, Kurosumi M et al (2006) Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer 13:179–185
Takei H, Suemasu K, Kurosumi M et al (2007) Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer 14:16–24
Kurosumi M, Akiyama F, Iwase T et al (2001) Histopathological criteria for assessment of therapeutic response in breast cancer. Breast Cancer 8:1–2
Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15:5–7
International Union Against Cancer UICC (2002) In: Sobin LH, Witterkind CH (eds) TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York
Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539–546
van Deurzen CH, Vriens BE, Tjan-Heijnen VC et al (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45:3124–3130
Kelly AM, Dwamena B, Cronin P, Carlos RC (2009) Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis. Acad Radiol 16:551–563
Jeruss JS, Newman LA, Ayers GD et al (2008) Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 112:2646–2654
Gimbergues P, Abrial C, Durando X et al (2009) Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients. Ann Surg Oncol 16:1946–1951
Ozmen V, Unal ES, Muslumanoglu ME et al (2010) Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol 36:23–29
Pecha V, Kolarik D, Kozevnikova R et al (2011) Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Cancer 117:4606–4616
Tausch C, Konstantiniuk P, Kugler F et al (2008) Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol 15:3378–3383
Shimazu K, Tamaki Y, Taguchi T et al (2008) Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 15:1717–1722
Rubio IT, Aznar F, Lirola J et al (2010) Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol 17:235–239